project id: TCGA-COAD; case submitter id: TCGA-DM-A1DA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 7.0; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26169; days to death: 228; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1928; year of death: 1999; age at diagnosis: 26169; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 228.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 1999; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4012; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-DM-A1DA-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 75.0;